Urine test to help women in Kenya stick with PrEP
Part of Infections clinical trials.
This study tests a simple urine test to check if your body is getting enough PrEP (a daily pill that prevents HIV). If the test shows you need more support, it may help you stick with taking PrEP regularly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are HIV-negative (confirmed by a test)
- You have been taking daily oral PrEP for at least one month
- You can get your PrEP refills at a study clinic in Kiambu County
- You want to keep taking oral PrEP even if you've had trouble remembering
- You are not in a relationship with an HIV-positive partner (or you are, but the trial has specific rules)
- You live in Kiambu County and won't move away in the next year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a program called 'PrEP My Way' can help young women in Kenya stick with taking PrEP pills to prevent HIV. It's designed for women ages 16–24 who are just starting PrEP in Kisumu County.
This trial tests a “one-stop” support pathway meant to make it easier for PrEP clinics in Kenya to deliver PrEP care. It involves interviews with people using PrEP services and with healthcare and policy leaders who help run or guide PrEP delivery.
This trial tests whether a simple urine test can help people living with HIV who have not yet achieved viral suppression. The test is done right at the clinic to quickly check if their HIV medication is being taken correctly, so their doctor can offer extra support.
This study looks at whether young women can get PrEP, a daily pill that prevents HIV, from local pharmacies instead of clinics. It aims to make it easier for adolescent girls and young women to start and continue PrEP in selected areas of Tanzania.
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
Hear when a new PrEP Adherence Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.